+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Influenza Vaccine Market by Vaccine Type (Inactivated, Live Attenuated, Recombinant), Age Group (Adult, Geriatric, Pediatric), Dosage, Presentation, Distribution Channel, End User - Global Forecast 2025-2030- Product Image
Influenza Vaccine Market by Vaccine Type (Inactivated, Live Attenuated, Recombinant), Age Group (Adult, Geriatric, Pediatric), Dosage, Presentation, Distribution Channel, End User - Global Forecast 2025-2030- Product Image
Sale

Influenza Vaccine Market by Vaccine Type (Inactivated, Live Attenuated, Recombinant), Age Group (Adult, Geriatric, Pediatric), Dosage, Presentation, Distribution Channel, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 186 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5012972
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The influenza vaccine market is experiencing strategic shifts driven by scientific innovation, operational realignment, and stakeholder collaboration. Robust immunization strategies and advanced manufacturing are redefining vaccine accessibility, regulatory trajectories, and public health outcomes. Senior decision-makers can leverage this report’s actionable insights to navigate evolving demand, complex supply chains, and regional policy frameworks.

Market Snapshot: Influenza Vaccine Market Outlook

The Influenza Vaccine Market grew from USD 8.61 billion in 2024 to USD 9.41 billion in 2025. It is expected to continue growing at a CAGR of 9.06%, reaching USD 14.50 billion by 2030. Key forces shaping this market include heightened public awareness, innovative vaccine constructs, and regulatory adjustments. Producers and healthcare organizations are refining immunization frameworks while strengthening supply chain resilience to address shifting epidemiological and commercial dynamics.

Scope & Segmentation

This report provides a deep assessment of the competitive landscape, innovation trends, and regional developments within the influenza vaccine sector, precisely segmented as follows:
  • Vaccine Types: Inactivated, Live Attenuated, Recombinant
  • Age Groups: Adult, Geriatric, Pediatric
  • Dosage Modalities: Multi Dose, Single Dose
  • Presentation Forms: Glass Prefilled Syringe, Plastic Prefilled Syringe, Multi Dose Vial, Single Dose Vial
  • Distribution Channels: Direct Sales, Hospital Pharmacies
  • End Users: Outpatient Clinics, Specialty Clinics, Private Hospitals, Public Hospitals
  • Regions: Americas (United States, California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Companies: Sanofi S.A., CSL Limited, GlaxoSmithKline plc, AstraZeneca plc, Pfizer Inc., Sinovac Biotech Ltd., China National Pharmaceutical Group Co., Ltd., Serum Institute of India Private Limited, Changchun BCH Bioengineering Co., Ltd., Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd.

Key Takeaways for Senior Decision-Makers

  • Advancements in recombinant DNA technologies have rapidly accelerated novel vaccine development, offering improved targeting and scalability for fluctuating seasonal demand.
  • Single-use bioreactors and modular production facilities introduce process agility, allowing manufacturers to quickly respond to market needs and adapt to disruptive events.
  • Digital integration within distribution chains, including direct-to-consumer channels and IoT-enabled cold chain monitoring, enhances delivery precision and reduces coverage gaps in underserved populations.
  • Collaborative partnerships between public and private sectors facilitate accelerated research, streamlined procurement, and advancement of universal vaccine candidates.
  • Regional structural differences—such as public health infrastructure strength, regulatory harmonization, and local manufacturing growth—demand tailored engagement to maximize uptake and operational efficiency.

Tariff Impact and Supply Chain Dynamics

Emerging tariff changes in major markets are influencing sourcing strategies, pushing manufacturers to diversify supplier networks and adopt long-term procurement agreements. These policies have prompted localized production initiatives and greater backward integration to manage rising costs and mitigate cross-border shipment disruptions. Health providers are adjusting procurement and inventory management approaches, focusing on buffered stock levels and dynamic tendering to ensure stable vaccine availability.

Influenza Vaccine Market: Methodology & Data Sources

This report synthesizes primary interviews with industry executives, regulatory authorities, and supply chain experts, paired with comprehensive secondary research from journals, government data, and peer-reviewed studies. Analytical tools include trend analysis and regional comparisons. Quality is upheld through subject-matter peer reviews, data triangulation, and sensitivity analyses for recommendations that remain relevant amid evolving industry parameters.

Why This Report Matters

  • Equips senior executives, investors, and public health officials with insights for strategic planning and investment prioritization within the influenza vaccine market.
  • Clarifies the impact of technology, regulatory policy, and operational innovations on vaccine accessibility, efficacy, and market segmentation.
  • Enables identification of emerging opportunities, mitigates potential risks, and supports informed decision-making in an environment subject to policy and supply chain volatility.

Conclusion

As the influenza vaccine landscape evolves through new technologies, regulatory shifts, and strategic collaborations, effective stakeholder engagement and agile operational planning become crucial. Use this report’s insights to refine your approach and capitalize on changing market conditions.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Expansion of mRNA technology applications in quadrivalent and universal influenza vaccine development
5.2. Adoption of high-dose and adjuvanted vaccine formulations for enhanced immunogenicity in elderly populations
5.3. Implementation of digital health platforms for real-time influenza vaccine efficacy monitoring and reporting
5.4. Regulatory fast-track approvals and emergency use authorizations accelerating novel influenza vaccine candidates
5.5. Strategic collaboration between pharmaceutical companies and local manufacturers to address regional vaccine shortages
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Influenza Vaccine Market, by Vaccine Type
8.1. Introduction
8.2. Inactivated
8.3. Live Attenuated
8.4. Recombinant
9. Influenza Vaccine Market, by Age Group
9.1. Introduction
9.2. Adult
9.3. Geriatric
9.4. Pediatric
10. Influenza Vaccine Market, by Dosage
10.1. Introduction
10.2. Multi Dose
10.3. Single Dose
11. Influenza Vaccine Market, by Presentation
11.1. Introduction
11.2. Prefilled Syringe
11.2.1. Glass Prefilled Syringe
11.2.2. Plastic Prefilled Syringe
11.3. Vial
11.3.1. Multi Dose Vial
11.3.2. Single Dose Vial
12. Influenza Vaccine Market, by Distribution Channel
12.1. Introduction
12.2. Direct Sales
12.3. Hospital Pharmacies
13. Influenza Vaccine Market, by End User
13.1. Introduction
13.2. Clinics
13.2.1. Outpatient Clinics
13.2.2. Specialty Clinics
13.3. Hospitals
13.3.1. Private Hospitals
13.3.2. Public Hospitals
14. Americas Influenza Vaccine Market
14.1. Introduction
14.2. United States
14.3. Argentina
14.4. Canada
14.5. Mexico
14.6. Brazil
15. Europe, Middle East & Africa Influenza Vaccine Market
15.1. Introduction
15.2. Nigeria
15.3. Qatar
15.4. Spain
15.5. Israel
15.6. Denmark
15.7. South Africa
15.8. Saudi Arabia
15.9. United Arab Emirates
15.10. Italy
15.11. Switzerland
15.12. Poland
15.13. Norway
15.14. Finland
15.15. France
15.16. Netherlands
15.17. Turkey
15.18. Sweden
15.19. Russia
15.20. Germany
15.21. Egypt
15.22. United Kingdom
16. Asia-Pacific Influenza Vaccine Market
16.1. Introduction
16.2. South Korea
16.3. Australia
16.4. Indonesia
16.5. Philippines
16.6. Singapore
16.7. Malaysia
16.8. Thailand
16.9. India
16.10. Vietnam
16.11. Taiwan
16.12. Japan
16.13. China
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Sanofi S.A.
17.3.2. CSL Limited
17.3.3. GlaxoSmithKline plc
17.3.4. AstraZeneca plc
17.3.5. Pfizer Inc.
17.3.6. Sinovac Biotech Ltd.
17.3.7. China National Pharmaceutical Group Co., Ltd.
17.3.8. Serum Institute of India Private Limited
17.3.9. Changchun BCH Bioengineering Co., Ltd.
17.3.10. Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. INFLUENZA VACCINE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL INFLUENZA VACCINE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 8. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY DOSAGE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY DOSAGE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY PRESENTATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY PRESENTATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS INFLUENZA VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS INFLUENZA VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES INFLUENZA VACCINE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES INFLUENZA VACCINE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA INFLUENZA VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA INFLUENZA VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC INFLUENZA VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC INFLUENZA VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. INFLUENZA VACCINE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. INFLUENZA VACCINE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. INFLUENZA VACCINE MARKET: RESEARCHAI
FIGURE 28. INFLUENZA VACCINE MARKET: RESEARCHSTATISTICS
FIGURE 29. INFLUENZA VACCINE MARKET: RESEARCHCONTACTS
FIGURE 30. INFLUENZA VACCINE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. INFLUENZA VACCINE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL INFLUENZA VACCINE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL INFLUENZA VACCINE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY INACTIVATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY INACTIVATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY LIVE ATTENUATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY LIVE ATTENUATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY RECOMBINANT, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY RECOMBINANT, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY ADULT, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY GERIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY MULTI DOSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY MULTI DOSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY SINGLE DOSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY SINGLE DOSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY PRESENTATION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY PRESENTATION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY PREFILLED SYRINGE, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY PREFILLED SYRINGE, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY GLASS PREFILLED SYRINGE, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY GLASS PREFILLED SYRINGE, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY PLASTIC PREFILLED SYRINGE, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY PLASTIC PREFILLED SYRINGE, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY PREFILLED SYRINGE, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY PREFILLED SYRINGE, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY VIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY VIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY MULTI DOSE VIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY MULTI DOSE VIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY SINGLE DOSE VIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY SINGLE DOSE VIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY VIAL, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY VIAL, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY OUTPATIENT CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY OUTPATIENT CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL INFLUENZA VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS INFLUENZA VACCINE MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS INFLUENZA VACCINE MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS INFLUENZA VACCINE MARKET SIZE, BY PRESENTATION, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS INFLUENZA VACCINE MARKET SIZE, BY PRESENTATION, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS INFLUENZA VACCINE MARKET SIZE, BY PREFILLED SYRINGE, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS INFLUENZA VACCINE MARKET SIZE, BY PREFILLED SYRINGE, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS INFLUENZA VACCINE MARKET SIZE, BY VIAL, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS INFLUENZA VACCINE MARKET SIZE, BY VIAL, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS INFLUENZA VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS INFLUENZA VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS INFLUENZA VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS INFLUENZA VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS INFLUENZA VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS INFLUENZA VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS INFLUENZA VACCINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS INFLUENZA VACCINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES INFLUENZA VACCINE MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES INFLUENZA VACCINE MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES INFLUENZA VACCINE MARKET SIZE, BY PRESENTATION, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES INFLUENZA VACCINE MARKET SIZE, BY PRESENTATION, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES INFLUENZA VACCINE MARKET SIZE, BY PREFILLED SYRINGE, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES INFLUENZA VACCINE MARKET SIZE, BY PREFILLED SYRINGE, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES INFLUENZA VACCINE MARKET SIZE, BY VIAL, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES INFLUENZA VACCINE MARKET SIZE, BY VIAL, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES INFLUENZA VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES INFLUENZA VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES INFLUENZA VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES INFLUENZA VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES INFLUENZA VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES INFLUENZA VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES INFLUENZA VACCINE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES INFLUENZA VACCINE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 117. ARGENTINA INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 118. ARGENTINA INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 119. ARGENTINA INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 120. ARGENTINA INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 121. ARGENTINA INFLUENZA VACCINE MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 122. ARGENTINA INFLUENZA VACCINE MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 123. ARGENTINA INFLUENZA VACCINE MARKET SIZE, BY PRESENTATION, 2018-2024 (USD MILLION)
TABLE 124. ARGENTINA INFLUENZA VACCINE MARKET SIZE, BY PRESENTATION, 2025-2030 (USD MILLION)
TABLE 125. ARGENTINA INFLUENZA VACCINE MARKET SIZE, BY PREFILLED SYRINGE, 2018-2024 (USD MILLION)
TABLE 126. ARGENTINA INFLUENZA VACCINE MARKET SIZE, BY PREFILLED SYRINGE, 2025-2030 (USD MILLION)
TABLE 127. ARGENTINA INFLUENZA VACCINE MARKET SIZE, BY VIAL, 2018-2024 (USD MILLION)
TABLE 128. ARGENTINA INFLUENZA VACCINE MARKET SIZE, BY VIAL, 2025-2030 (USD MILLION)
TABLE 129. ARGENTINA INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 130. ARGENTINA INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 131. ARGENTINA INFLUENZA VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 132. ARGENTINA INFLUENZA VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 133. ARGENTINA INFLUENZA VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 134. ARGENTINA INFLUENZA VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 135. ARGENTINA INFLUENZA VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 136. ARGENTINA INFLUENZA VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 137. CANADA INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 138. CANADA INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 139. CANADA INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 140. CANADA INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 141. CANADA INFLUENZA VACCINE MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 142. CANADA INFLUENZA VACCINE MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 143. CANADA INFLUENZA VACCINE MARKET SIZE, BY PRESENTATION, 2018-2024 (USD MILLION)
TABLE 144. CANADA INFLUENZA VACCINE MARKET SIZE, BY PRESENTATION, 2025-2030 (USD MILLION)
TABLE 145. CANADA INFLUENZA VACCINE MARKET SIZE, BY PREFILLED SYRINGE, 2018-2024 (USD MILLION)
TABLE 146. CANADA INFLUENZA VACCINE MARKET SIZE, BY PREFILLED SYRINGE, 2025-2030 (USD MILLION)
TABLE 147. CANADA INFLUENZA VACCINE MARKET SIZE, BY VIAL, 2018-2024 (USD MILLION)
TABLE 148. CANADA INFLUENZA VACCINE MARKET SIZE, BY VIAL, 2025-2030 (USD MILLION)
TABLE 149. CANADA INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 150. CANADA INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 151. CANADA INFLUENZA VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 152. CANADA INFLUENZA VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 153. CANADA INFLUENZA VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 154. CANADA INFLUENZA VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 155. CANADA INFLUENZA VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 156. CANADA INFLUENZA VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 157. MEXICO INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 158. MEXICO INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 159. MEXICO INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 160. MEXICO INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 161. MEXICO INFLUENZA VACCINE MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 162. MEXICO INFLUENZA VACCINE MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 163. MEXICO INFLUENZA VACCINE MARKET SIZE, BY PRESENTATION, 2018-2024 (USD MILLION)
TABLE 164. MEXICO INFLUENZA VACCINE MARKET SIZE, BY PRESENTATION, 2025-2030 (USD MILLION)
TABLE 165. MEXICO INFLUENZA VACCINE MARKET SIZE, BY PREFILLED SYRINGE, 2018-2024 (USD MILLION)
TABLE 166. MEXICO INFLUENZA VACCINE MARKET SIZE, BY PREFILLED SYRINGE, 2025-2030 (USD MILLION)
TABLE 167. MEXICO INFLUENZA VACCINE MARKET SIZE, BY VIAL, 2018-2024 (USD MILLION)
TABLE 168. MEXICO INFLUENZA VACCINE MARKET SIZE, BY VIAL, 2025-2030 (USD MILLION)
TABLE 169. MEXICO INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 170. MEXICO INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 171. MEXICO INFLUENZA VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 172. MEXICO INFLUENZA VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 173. MEXICO INFLUENZA VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 174. MEXICO INFLUENZA VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 175. MEXICO INFLUENZA VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 176. MEXICO INFLUENZA VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL INFLUENZA VACCINE MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL INFLUENZA VACCINE MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL INFLUENZA VACCINE MARKET SIZE, BY PRESENTATION, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL INFLUENZA VACCINE MARKET SIZE, BY PRESENTATION, 2025-2030 (USD MILLION)
TABLE 185. BRAZIL INFLUENZA VACCINE MARKET SIZE, BY PREFILLED SYRINGE, 2018-2024 (USD MILLION)
TABLE 186. BRAZIL INFLUENZA VACCINE MARKET SIZE, BY PREFILLED SYRINGE, 2025-2030 (USD MILLION)
TABLE 187. BRAZIL INFLUENZA VACCINE MARKET SIZE, BY VIAL, 2018-2024 (USD MILLION)
TABLE 188. BRAZIL INFLUENZA VACCINE MARKET SIZE, BY VIAL, 2025-2030 (USD MILLION)
TABLE 189. BRAZIL INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL INFLUENZA VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL INFLUENZA VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL INFLUENZA VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL INFLUENZA VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL INFLUENZA VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL INFLUENZA VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA INFLUENZA VACCINE MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA INFLUENZA VACCINE MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA INFLUENZA VACCINE MARKET SIZE, BY PRESENTATION, 2018-2024 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA INFLUENZA VACCINE MARKET SIZE, BY PRESENTATION, 2025-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA INFLUENZA VACCINE MARKET SIZE, BY PREFILLED SYRINGE, 2018-2024 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA INFLUENZA VACCINE MARKET SIZE, BY PREFILLED SYRINGE, 2025-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA INFLUENZA VACCINE MARKET SIZE, BY VIAL, 2018-2024 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA INFLUENZA VACCINE MARKET SIZE, BY VIAL, 2025-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA INFLUENZA VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA INFLUENZA VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA INFLUENZA VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA INFLUENZA VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA INFLUENZA VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA INFLUENZA VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA INFLUENZA VACCINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA INFLUENZA VACCINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 219. NIGERIA INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 220. NIGERIA INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 221. NIGERIA INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 222. NIGERIA INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 223. NIGERIA INFLUENZA VACCINE MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 224. NIGERIA INFLUENZA VACCINE MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 225. NIGERIA INFLUENZA VACCINE MARKET SIZE, BY PRESENTATION, 2018-2024 (USD MILLION)
TABLE 226. NIGERIA INFLUENZA VACCINE MARKET SIZE, BY PRESENTATION, 2025-2030 (USD MILLION)
TABLE 227. NIGERIA INFLUENZA VACCINE MARKET SIZE, BY PREFILLED SYRINGE, 2018-2024 (USD MILLION)
TABLE 228. NIGERIA INFLUENZA VACCINE MARKET SIZE, BY PREFILLED SYRINGE, 2025-2030 (USD MILLION)
TABLE 229. NIGERIA INFLUENZA VACCINE MARKET SIZE, BY VIAL, 2018-2024 (USD MILLION)
TABLE 230. NIGERIA INFLUENZA VACCINE MARKET SIZE, BY VIAL, 2025-2030 (USD MILLION)
TABLE 231. NIGERIA INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 232. NIGERIA INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 233. NIGERIA INFLUENZA VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 234. NIGERIA INFLUENZA VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 235. NIGERIA INFLUENZA VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 236. NIGERIA INFLUENZA VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 237. NIGERIA INFLUENZA VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 238. NIGERIA INFLUENZA VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 239. QATAR INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 240. QATAR INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 241. QATAR INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 242. QATAR INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 243. QATAR INFLUENZA VACCINE MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 244. QATAR INFLUENZA VACCINE MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 245. QATAR INFLUENZA VACCINE MARKET SIZE, BY PRESENTATION, 2018-2024 (USD MILLION)
TABLE 246. QATAR INFLUENZA VACCINE MARKET SIZE, BY PRESENTATION, 2025-2030 (USD MILLION)
TABLE 247. QATAR INFLUENZA VACCINE MARKET SIZE, BY PREFILLED SYRINGE, 2018-2024 (USD MILLION)
TABLE 248. QATAR INFLUENZA VACCINE MARKET SIZE, BY PREFILLED SYRINGE, 2025-2030 (USD MILLION)
TABLE 249. QATAR INFLUENZA VACCINE MARKET SIZE, BY VIAL, 2018-2024 (USD MILLION)
TABLE 250. QATAR INFLUENZA VACCINE MARKET SIZE, BY VIAL, 2025-2030 (USD MILLION)
TABLE 251. QATAR INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 252. QATAR INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 253. QATAR INFLUENZA VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 254. QATAR INFLUENZA VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 255. QATAR INFLUENZA VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 256. QATAR INFLUENZA VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 257. QATAR INFLUENZA VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 258. QATAR INFLUENZA VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 259. SPAIN INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 260. SPAIN INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 261. SPAIN INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 262. SPAIN INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 263. SPAIN INFLUENZA VACCINE MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 264. SPAIN INFLUENZA VACCINE MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 265. SPAIN INFLUENZA VACCINE MARKET SIZE, BY PRESENTATION, 2018-2024 (USD MILLION)
TABLE 266. SPAIN INFLUENZA VACCINE MARKET SIZE, BY PRESENTATION, 2025-2030 (USD MILLION)
TABLE 267. SPAIN INFLUENZA VACCINE MARKET SIZE, BY PREFILLED SYRINGE, 2018-2024 (USD MILLION)
TABLE 268. SPAIN INFLUENZA VACCINE MARKET SIZE, BY PREFILLED SYRINGE, 2025-2030 (USD MILLION)
TABLE 269. SPAIN INFLUENZA VACCINE MARKET SIZE, BY VIAL, 2018-2024 (USD MILLION)
TABLE 270. SPAIN INFLUENZA VACCINE MARKET SIZE, BY VIAL, 2025-2030 (USD MILLION)
TABLE 271. SPAIN INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 272. SPAIN INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 273. SPAIN INFLUENZA VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 274. SPAIN INFLUENZA VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 275. SPAIN INFLUENZA VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 276. SPAIN INFLUENZA VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 277. SPAIN INFLUENZA VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 278. SPAIN INFLUENZA VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 279. ISRAEL INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 280. ISRAEL INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 281. ISRAEL INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 282. ISRAEL INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 283. ISRAEL INFLUENZA VACCINE MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 284. ISRAEL INFLUENZA VACCINE MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 285. ISRAEL INFLUENZA VACCINE MARKET SIZE, BY PRESENTATION, 2018-2024 (USD MILLION)
TABLE 286. ISRAEL INFLUENZA VACCINE MARKET SIZE, BY PRESENTATION, 2025-2030 (USD MILLION)
TABLE 287. ISRAEL INFLUENZA VACCINE MARKET SIZE, BY PREFILLED SYRINGE, 2018-2024 (USD MILLION)
TABLE 288. ISRAEL INFLUENZA VACCINE MARKET SIZE, BY PREFILLED SYRINGE, 2025-2030 (USD MILLION)
TABLE 289. ISRAEL INFLUENZA VACCINE MARKET SIZE, BY VIAL, 2018-2024 (USD MILLION)
TABLE 290. ISRAEL INFLUENZA VACCINE MARKET SIZE, BY VIAL, 2025-2030 (USD MILLION)
TABLE 291. ISRAEL INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 292. ISRAEL INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 293. ISRAEL INFLUENZA VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 294. ISRAEL INFLUENZA VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 295. ISRAEL INFLUENZA VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 296. ISRAEL INFLUENZA VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 297. ISRAEL INFLUENZA VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 298. ISRAEL INFLUENZA VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 299. DENMARK INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 300. DENMARK INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 301. DENMARK INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 302. DENMARK INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 303. DENMARK INFLUENZA VACCINE MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 304. DENMARK INFLUENZA VACCINE MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 305. DENMARK INFLUENZA VACCINE MARKET SIZE, BY PRESENTATION, 2018-2024 (USD MILLION)
TABLE 306. DENMARK INFLUENZA VACCINE MARKET SIZE, BY PRESENTATION, 2025-2030 (USD MILLION)
TABLE 307. DENMARK INFLUENZA VACCINE MARKET SIZE, BY PREFILLED SYRINGE, 2018-2024 (USD MILLION)
TABLE 308. DENMARK INFLUENZA VACCINE MARKET SIZE, BY PREFILLED SYRINGE, 2025-2030 (USD MILLION)
TABLE 309. DENMARK INFLUENZA VACCINE MARKET SIZE, BY VIAL, 2018-2024 (USD MILLION)
TABLE 310. DENMARK INFLUENZA VACCINE MARKET SIZE, BY VIAL, 2025-2030 (USD MILLION)
TABLE 311. DENMARK INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 312. DENMARK INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 313. DENMARK INFLUENZA VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 314. DENMARK INFLUENZA VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 315. DENMARK INFLUENZA VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 316. DENMARK INFLUENZA VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 317. DENMARK INFLUENZA VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 318. DENMARK INFLUENZA VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 319. SOUTH AFRICA INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 320. SOUTH AFRICA INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 321. SOUTH AFRICA INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 322. SOUTH AFRICA INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 323. SOUTH AFRICA INFLUENZA VACCINE MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 324. SOUTH AFRICA INFLUENZA VACCINE MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 325. SOUTH AFRICA INFLUENZA VACCINE MARKET SIZE, BY PRESENTATION, 2018-2024 (USD MILLION)
TABLE 326. SOUTH AFRICA INFLUENZA VACCINE MARKET SIZE, BY PRESENTATION, 2025-2030 (USD MILLION)
TABLE 327. SOUTH AFRICA INFLUENZA VACCINE MARKET SIZE, BY PREFILLED SYRINGE, 2018-2024 (USD MILLION)
TABLE 328. SOUTH AFRICA INFLUENZA VACCINE MARKET SIZE, BY PREFILLED SYRINGE, 2025-2030 (USD MILLION)
TABLE 329. SOUTH AFRICA INFLUENZA VACCINE MARKET SIZE, BY VIAL, 2018-2024 (USD MILLION)
TABLE 330. SOUTH AFRICA INFLUENZA VACCINE MARKET SIZE, BY VIAL, 2025-2030 (USD MILLION)
TABLE 331. SOUTH AFRICA INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 332. SOUTH AFRICA INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 333. SOUTH AFRICA INFLUENZA VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 334. SOUTH AFRICA INFLUENZA VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 335. SOUTH AFRICA INFLUENZA VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 336. SOUTH AFRICA INFLUENZA VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 337. SOUTH AFRICA INFLUENZA VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 338. SOUTH AFRICA INFLUENZA VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 339. SAUDI ARABIA INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 340. SAUDI ARABIA INFLUENZA VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 341. SAUDI ARABIA INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 342. SAUDI ARABIA INFLUENZA VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 343. SAUDI ARABIA INFLUENZA VACCINE MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 344. SAUDI ARABIA INFLUENZA VACCINE MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 345. SAUDI ARABIA INFLUENZA VACCINE MARKET SIZE, BY PRESENTATION, 2018-2024 (USD MILLION)
TABLE 346. SAUDI ARABIA INFLUENZA VACCINE MARKET SIZE, BY PRESENTATION, 2025-2030 (USD MILLION)
TABLE 347. SAUDI ARABIA INFLUENZA VACCINE MARKET SIZE, BY PREFILLED SYRINGE, 2018-2024 (USD MILLION)
TABLE 348. SAUDI ARABIA INFLUENZA VACCINE MARKET SIZE, BY PREFILLED SYRINGE, 2025-2030 (USD MILLION)
TABLE 349. SAUDI ARABIA INFLUENZA VACCINE MARKET SIZE, BY VIAL, 2018-2024 (USD MILLION)
TABLE 350. SAUDI ARABIA INFLUENZA VACCINE MARKET SIZE, BY VIAL, 2025-2030 (USD MILLION)
TABLE 351. SAUDI ARABIA INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 352. SAUDI ARABIA INFLUENZA VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 353. SAUDI ARABIA INFLUENZA VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 354. SAUDI ARABIA INFLUENZA VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 355. SAUDI ARABIA INFLUENZA VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 356. SAUDI ARABIA INFLUENZA

Samples

Loading
LOADING...

Companies Mentioned

  • Sanofi S.A.
  • CSL Limited
  • GlaxoSmithKline plc
  • AstraZeneca plc
  • Pfizer Inc.
  • Sinovac Biotech Ltd.
  • China National Pharmaceutical Group Co., Ltd.
  • Serum Institute of India Private Limited
  • Changchun BCH Bioengineering Co., Ltd.
  • Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd.

Table Information

Report AttributeDetails
No. of Pages186
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 9.41 Billion
Forecasted Market Value ( USD ) by 2030 $ 14.5 Billion
Compound Annual Growth Rate9.0%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Inactivated Influenza Vaccine Global Market Report 2025 - Product Image

Inactivated Influenza Vaccine Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Travel Vaccines - Global Strategic Business Report - Product Image

Travel Vaccines - Global Strategic Business Report

  • Report
  • 281 Pages
  • Global
From
Viral Vaccines Market Size, Share, Forecast, & Trends Analysis by Form Type, Route of Administration, Approach, Indication, Packaging - Global Forecast to 2031 - Product Image

Viral Vaccines Market Size, Share, Forecast, & Trends Analysis by Form Type, Route of Administration, Approach, Indication, Packaging - Global Forecast to 2031

  • Report
  • 239 Pages
  • Global
From
Influenza Virus Lysate Vaccine Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type - Product Image

Influenza Virus Lysate Vaccine Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • 79 Pages
  • Global
From
Influenza Vaccine Market: Analysis by Valency, Vaccine Type, Technology, Age Group, Route of Administration, Distribution Channel, and Region - Size, Trends and Forecasts to 2030 - Product Image

Influenza Vaccine Market: Analysis by Valency, Vaccine Type, Technology, Age Group, Route of Administration, Distribution Channel, and Region - Size, Trends and Forecasts to 2030

  • Report
  • 165 Pages
  • Global
From

About the Flu Vaccine Market

The Flu Vaccine market is a subset of the larger Vaccines market, which is composed of products designed to prevent and treat infectious diseases. Flu Vaccines are specifically designed to protect against influenza, a highly contagious virus that can cause severe illness and even death. Flu Vaccines are typically administered annually, and are recommended for people of all ages, including pregnant women and those with chronic health conditions. Flu Vaccines are typically developed by pharmaceutical companies, and are then approved and distributed by government health agencies. In addition to traditional flu vaccines, there are also recombinant vaccines, which are produced using genetic engineering techniques. Companies in the Flu Vaccine market include Sanofi Pasteur, GlaxoSmithKline, Merck & Co., Pfizer, and Novartis. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.